Interstitial granulomatous dermatitis (IGD) has been associated with pharmacotherapy, various autoimmune conditions, and hematologic malignant conditions. Herein, we report a patient in whom IGD was the initial manifestation of a previously undiagnosed myeloma.
Article InformationCorresponding Author: Sabra Abner, MD, Division of Dermatology, Department of Medicine, The University of Louisville School of Medicine, 3810 Springhurst Blvd, Ste 200, Louisville, KY 40241 (email@example.com).
Published Online: June 3, 2015. doi:10.1001/jamadermatol.2015.1160.
Conflict of Interest Disclosures: None reported.
Disclaimer: Dr Callen is associate editor of JAMA Dermatology, but he was not involved in any of the decisions regarding review of the manuscript or its acceptance.